<DOC>
	<DOCNO>NCT01467791</DOCNO>
	<brief_summary>Registry follow patient sarcoidosis associate pulmonary hypertension</brief_summary>
	<brief_title>Registry Sarcoidosis Associated Pulmonary Hypertension ( RESAPH )</brief_title>
	<detailed_description>This multi center registry sarcoidosis associate pulmonary hypertension ( SAPH ) . With registry , investigator characterize demographic , clinical course , hemodynamics , pulmonary physiology , disease management sarcoidosis associate pulmonary hypertension United States . The investigator also compare feature non-US site .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Sarcoidosis</mesh_term>
	<criteria>Patients sarcoidosis define ATS/WASOG statement Patients pulmonary hypertension confirm right heart catheterization Patients willing provide write informed consent Unwillingness provide assurance complete follow visit study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ambrisentan</keyword>
	<keyword>Bosentan</keyword>
	<keyword>Iloprost</keyword>
</DOC>